Indefinite Delivery Contract HHSO100201700016I

The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded an indefinite delivery contract to the UK Health Security Agency to support the Biomedical Advanced Research and Development Authority. The single award IDV has a potential value of $100 million and a period of performance through September 2027. Two task orders have been issued against the contract to date, totaling over $18 million, for biological animal model and medical...

This is a multiple-award Indefinite Delivery Contract (IDC) with a $80,000,000 ceiling value, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to the UK Health Security Agency (formerly Public Health England), a government agency in the United Kingdom. The contract is for the provision of pre-clinical models and services related to infectious disease research and development, including biological...

The federal contract IDV award provides indefinite delivery of nonclinical biological services to the Department of Health and Human Services (HHS), specifically the Office of the Assistant Secretary for Preparedness and Response (ASPR). The purpose is to establish a network of Good Laboratory Practices (GLP) facilities capable of conducting animal testing and other analytical services to support the development of medical countermeasures against chemical, biological, radiological, and nuclear...

The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $146.3 million single-award Indefinite Delivery Contract (IDC) to the UK Health Security Agency (formerly Public Health England) to provide preclinical services in support of the development of medical countermeasures against chemical, biological, radiological, and nuclear threats. The contract includes task areas for small animal models, non-human primate models, animal replacement and non-traditional animal models,...

The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a single award indefinite delivery contract to American Type Culture Collection to provide preclinical services supporting the development of biopharmaceutical therapeutics and diagnostics for infectious diseases. With a potential value of $30 million and a period of performance from January 2023 through September 2030, the contract enables task orders to be issued across five areas: product...

This is a single-award Indefinite Delivery Contract (IDC) awarded by the U.S. Food and Drug Administration (FDA), a civilian federal agency, to the UK Health Security Agency (formerly Public Health England). The $2,380,824.61 contract is focused on comparing Ebola virus infection and disease in animal models and humans, as well as assessing animal models for medical countermeasure development. The contract has a period of performance through October 2022 and is not set aside for any...

The federal contract IDV award, valued at up to $146.3 million over a 7-year ordering period, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to the Ministry of Defence (D S T L) of the United Kingdom. The contract aims to provide a broad range of animal and animal replacement models to evaluate the efficacy of candidate countermeasures, including vaccines, therapeutics, and diagnostics, against infectious agents under NIAID's purview. This includes models for RNA...

This indefinite delivery contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the Ministry of Defence (doing business as D S T L), a U.K. government entity, to provide pre-clinical models of infectious diseases. The $40 million multiple-award contract runs from July 2017 to July 2024 and is part of NIAID's Preclinical Models of Infectious Diseases program. Under this contract, the Ministry of Defence will conduct research and...

This is a single-award Indefinite Delivery Contract issued by the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned for-profit organization that manufactures biologics. The Diagnostics Pre-Clinical Services Program IDIQ contract has a potential value of $24,000,000 over a 7-year ordering period ending June 2030. Under this contract, ABL will provide a broad range of preclinical diagnostic...

This single-award IDV was issued by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to provide centralized clinical laboratory services in support of clinical research trials. With a potential value of $5,000,000 and a period of performance through May 2026, the awardee PPD Development LP will deliver services including specimen handling, testing, data management, and clinical trial support. The originating...